NBIX

Neurocrine Biosciences
D

NBIX

120.100
USD
1.01
(0.85%)
مغلق
حجم التداول
44,933
الربح لكل سهم
5
العائد الربحي
-
P/E
41
حجم السوق
11,885,794,982
أصول ذات صلة
ALNY
ALNY
0.47
(0.16%)
289.82 USD
AMGN
AMGN
-0.04
(-0.01%)
271.89 USD
A
ARWR
-0.250
(-1.62%)
15.140 USD
BIIB
BIIB
-0.465
(-0.37%)
125.825 USD
GILD
GILD
0.670
(0.63%)
107.390 USD
ILMN
ILMN
-0.160
(-0.20%)
80.380 USD
REGN
REGN
-8.04
(-1.35%)
588.61 USD
S
SGMO
-0.02030
(-4.11%)
0.47370 USD
S
SRPT
-0.900
(-2.32%)
37.900 USD
VRTX
VRTX
1.79
(0.41%)
435.79 USD
المزيد
الأخبار المقالات

العنوان: Neurocrine Biosciences

القطاع: Healthcare
الصناعة: Drug Manufacturers - Specialty & Generic
Neurocrine Biosciences Inc engages in the discovery, development, and commercialization of drugs for the treatment of neurological and endocrine-related diseases and disorders in the United States. The company's products include INGREZZA for tardive dyskinesia and chorea associated with Huntington's disease; ALKINDI for adrenal insufficiency; Efmody capsules for classic congenital adrenal hyperplasia; Orilissa tablets for endometriosis; and Oriahnn capsules to treat uterine fibroids.